James Cassidy

Technik-/Wissenschafts-/F&E-Leiter bei SPRINGWORKS THERAPEUTICS, INC.

Vermögen: 1 Mio $ am 30.04.2024

65 Jahre

Health Technology

Consumer Services

Aktive Positionen von James Cassidy

Unternehmen	Position	Beginn	Ende
SPRINGWORKS THERAPEUTICS, INC.	Technik-/Wissenschafts-/F&E-Leiter	01.08.2021	-

Unternehmen	Position	Beginn	Ende
REGENERON PHARMACEUTICALS, INC.	Corporate Officer/Principal	01.02.2020	01.08.2021
Celgene LLC	Corporate Officer/Principal	01.11.2016	01.01.2020
BRISTOL-MYERS SQUIBB COMPANY	Corporate Officer/Principal	01.06.2013	01.10.2016
University of Glasgow	Corporate Officer/Principal	01.01.2002	01.01.2011
Hoffmann-La Roche, Inc. Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ.	Corporate Officer/Principal	-	-

University of Glasgow

Doctorate Degree

International

Vereinigte Staaten	6
Vereinigtes Königreich	2

Operativ

Corporate Officer/Principal	5
Chief Tech/Sci/R&D Officer	1
Doctorate Degree	1

Sektoral

Health Technology	5
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	3
SPRINGWORKS THERAPEUTICS, INC.	Health Technology
REGENERON PHARMACEUTICALS, INC.	Health Technology
BRISTOL-MYERS SQUIBB COMPANY	Health Technology

Private Unternehmen	2
Celgene LLC
Hoffmann-La Roche, Inc. Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ.	Health Technology